Kidney Week

Kidney Week 2020: Exhibitor Spotlights

Presented during Kidney Week 2020 Reimagined, the following Exhibitor Spotlight presentations highlight the latest advances in nephrology practices, therapies, services, and technologies and are available to view through March 31, 2021. The Exhibitor Spotlights are not Continuing Education (CE) activities.

A Novel Approach to Anemia - Introducing HIF SoPHIstication

Supported by Akebia Therapeutics, Inc.

view presentation

Oxalate and the Kidneys: Primary Hyperoxaluria in Practice

Supported by Alnylam Pharmaceuticals

view presentation

Shortening the Journey to Fabry Disease Diagnosis - Perspectives from a Patient and Nephrologist

Supported by Amicus Therapeutics

view presentation

Advancing the Science of Phosphate Absorption: Paracellular Pathway and Implications for Phosphorus Management

Supported by Ardelyx

view presentation

The Efficacy and Safety of LOKELMA® (sodium zirconium cyclosilicate)

Supported by AstraZeneca

view presentation

Anemia of CKD: A Changing Perspective Based on the HIF Pathway

Supported by AstraZeneca

view presentation

Lupus Nephritis: The Importance of Active Surveillance, Early Diagnoses, and Successful Treatment

Supported by Aurinia Pharmaceuticals

view presentation

Where There's Smoke, There's Fire: Uncovering the Role of Inflammation and Fibrosis in CKD Progression in T2D

Supported by Bayer

view presentation

AlloSure as a Tool for Surveillance of Renal Transplant Patients: Real World Evidence and Clinical Utility

Supported by CareDx

view presentation

Rethinking Fabry Disease: Reasons to Look into the Future

Supported by Chiesi Global Rare Diseases

view presentation

Lupus Nephritis: The CASE for Early Recognition and Management

Supported by GSK

view presentation

Discover the Genetic Etiology of Kidney Disease with Renasight

Supported by Natera

view presentation

IgA Nephropathy - Understanding the Role of the Complement Pathway

Supported by Novartis

view presentation

Minimize Risk of Iron Overload: Centralize Delivery With a Novel Approach to Anemia Management in Hemodialysis

Supported by Rockwell Medical

view presentation

Evolving Concepts in ADPKD

Supported by Sanofi Genzyme

view presentation

Understanding Innovative Endpoints in Glomerular Diseases

Supported by Travere Therapeutics (formerly Retrophin)

view presentation

Renal Phosphate Wasting Disorders: X-Linked Hypophosphatemia (XLH) and Tumor-Induced Osteomalacia (TIO)

Supported by Ultragenyx Pharmaceutical Inc.

view presentation